Has Diane Bonaccorsi received payments from drug or device companies?

Yes. Drug and device makers reported $4,838 in general payments to Diane Bonaccorsi across 305 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Diane Bonaccorsi did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Diane Bonaccorsi come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Diane Bonaccorsi

Family Medicine · Reading, PANPI 1235224841

Payments from drug & device makers

$4,838in general payments, 2019–2025

Across 305 payments — averaging $15.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amgen$484
AbbVie$450
Pfizer$418
AstraZeneca$343
Amarin Pharma, Inc.$279
Novo Nordisk$274
plus $3K from 45 others

What the payments were for

Food & beverage$4,72398%
Education$1152%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amgen(2 entities)	29	$484
AbbVie(2 entities)	26	$450
Pfizer	34	$418
AstraZeneca	23	$343
Amarin Pharma, Inc.	20	$279
Novo Nordisk	18	$274
Novartis	15	$264
GSK	15	$227
Lilly USA, LLC	13	$186
Sanofi-aventis U.S. LLC	8	$120
Teva Pharmaceuticals USA, Inc.	7	$117
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	7	$111
Boehringer Ingelheim	6	$102
Merck	6	$96
Eisai Inc.	2	$94
Astellas Pharma US Inc	6	$94
Abbott	4	$73
Mannkind Corporation	4	$70
Johnson & Johnson	5	$69
Kowa Pharmaceuticals America, Inc.	5	$66
Takeda Pharmaceuticals U.S.A., Inc.	5	$63
IBSA Pharma Inc.	3	$59
Mylan Specialty L.p.	2	$58
Avanir Pharmaceuticals, Inc.	4	$56
Biofire Diagnostics, LLC	1	$54
Esperion Therapeutics, Inc.	3	$50
Daiichi Sankyo Inc.	2	$47
Ironwood Pharmaceuticals, Inc	3	$45
Biohaven Pharmaceuticals, Inc.	2	$39
Currax Pharmaceuticals LLC	3	$36
Paratek Pharmaceuticals, Inc.	2	$32
Sanofi Pasteur Inc.	2	$28
Optos, Inc.	1	$26
Otsuka America Pharmaceutical, Inc.	2	$26
Alnylam Pharmaceuticals Inc.	1	$23
Boston Scientific	1	$20
Clarus Therapeutics Inc.	1	$19
Bayer	1	$19
Shield Therapeutics Inc	1	$19
Nalpropion Pharmaceuticals LLC	1	$19
VBI Vaccine (delaware) Inc.	1	$19
Regeneron Healthcare Solutions, Inc.	1	$19
Bausch Health US, LLC	1	$16
Collegium Pharmaceutical, Inc.	1	$16
Sunovion Pharmaceuticals Inc.	1	$16
Arbor Pharmaceuticals, Inc.	1	$15
Urovant Sciences Inc	1	$15
Biogen	1	$14
Zyla Life Sciences, Inc.	1	$13
E.r. Squibb & Sons, L.L.C.	1	$12
Philips North America LLC	1	$11

How this compares

$4,838 in reported general payments places this provider in the 85th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Metformin Hcl	11	$134
Rosuvastatin Calcium	12	$123
Furosemide	13	$86

Paid to pharmacies, not to this prescriber.

Payments from drug & device makers

Who reported the general payments

How this compares

Most prescribed under Part D

Other family medicine in Reading